To review the role of sunlight in skin aging and skin cancer formation, and to provide guidelines on the use of sunscreens to minimize the adverse effects of sun damage.
Data Sources
A MEDLINE search of applicable articles on ultraviolet (UV) radiation, melanoma, sunscreens, and skin cancer, evaluating both human and animal studies. Published and unpublished original research as well as clinical experience were also used.
Data Synthesis
The interaction of UV radiation and skin type plays a central role in melanoma formation. Mortality from melanoma is highest in geographic locations near the equator, where UV intensity is greatest. The incidence of melanomas in light-complected individuals (skin types I-III) is several times higher than those with darker skin types (types IV-VI), even in similar geographic regions. The UVB portion of the spectrum appears to be primarily responsible for skin cancer formation and photoaging, while short wave UVA rays play a significant contributing role. Regular sunscreen use has been shown to reduce the formation of precancerous actinic keratoses (AK) lesions by 36%. A dose-response relationship has also been found between the amount of sunscreen used and AK formation.
Conclusions
Sunscreens have now been shown to reduce the carcinogenic effects of sunlight in humans. Patients should be advised of the long-term consequences of sun exposure and the benefits of regular sunscreen use.
Get full access to this article
View all access options for this article.
References
1.
WhitemanD, GreenA. Melanoma and sunburn.Cancer Causes Control1994; 5: 564–72.
2.
LoberCW, FenskeNA. Photoaging and the skin: differentiation and clinical response.Geriatrics1990; 45: 36–42.
3.
TaylorCR, SternRS, LeydenJJ, GilchrestBA. Photoaging/photodamage and photoprotection.J Am Acad Dermatol1990; 22: 1–15.
4.
YoungAR. Cumulative effects of ultraviolet radiation on the skin: cancer and photoaging.Semin Dermatol1990; 9: 25–31.
5.
YaarM, GilchrestB A. Cellular and molecular mechanisms of cutaneous aging.J Dermatol Surg Oncol1990; 16: 915–22.
6.
ChaseM. Tan worshippers may be giving skin lots more than glow.Wall Street Journal1995 June 5: section B, column 1.
7.
SambucoCP. Miniature swine as an animal model in photodermatology: factors influencing sunburn cell formation.Photodermatology1985; 2: 144–50.
8.
GallagherCH, CanfieldPJ, GreenoakGE, ReeveVE. Characterization and histogenesis of tumors in the hairless mouse produced by low-dosage incremental ultraviolet radiation.J Invest Dermatol1984; 83: 169–74.
9.
LeipoldB, RemyW. Use of avidin-biotin-peroxidase complex for measurement of UV lesions in human DNA by microELISA.J Immunol Methods1984; 66: 227–34.
10.
FourtanierA, BerrebiC. Miniature pig as an animal model to study photoaging.Photochem Photobiol1989; 50: 771–84.
11.
Environmental health criteria 160: ultraviolet radiation.WHO. Environmental health criteria.Vammala, Finland: World Health Organization,1994: 352.
12.
LydahlE, PhilipsonB. Infrared radiation and cataract. I. Epidemiologic investigation of iron and steel workers.Acta Ophthalmol1984; 62: 961–75.
13.
LydahlE. Infrared radiation and cataract.Acta Ophthalmol1984; 166(suppl): 1–63.
14.
LydahlE, PhilipsonB. Infrared radiation and cataract II. Epidemiologic investigation of glass workers.Acta Ophthalmol1984; 62: 976–92.
15.
JonesCS, TyringSK, LeePC, FineJD. Development of neuroendocrine (Merkel cell) carcinoma mixed with squamous cell carcinoma in erythema ab igne.Arch Dermatol1988; 124: 110–3.
16.
AkasakaT, KonS. Two cases of squamous cell carcinoma arising from erythema ab igne.J Dermatol1989; 99: 735–42.
17.
ArlingtonJH, LockmanDS. Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne.Arch Dermatol1979; 115: 1226–8.
18.
KligmanLH. Intensification of ultraviolet-induced dermal damage by infrared radiation.Arch Dermatol Res1982; 272: 229–38.
19.
KligmanLH. Photoaging. Manifestations, prevention, and treatment.Dermatol Clin1986; 4: 517–28.
20.
SamsWJ. Sun-induced aging. Clinical and laboratory observations in humans.Clin Geriatr Med1989; 5: 223–33.
21.
GriffithsCE. The clinical identification and quantification of photodamage.Br J Dermatol1992; 127(suppl 41): 37–42.
22.
RobinsonES, VandeBergJL, HubbardGB, DooleyTP. Malignant melanoma in ultraviolet irradiated laboratory opossums: initiation in sucking young, metastasis in adults, and xenograft behavior in nude mice.Cancer Res1994; 54: 5986–91.
23.
MaenpaaJ, DooleyT, WurzG, VandeBergJL, RobinsonES, EmshoffV. Topical toremifene: a new approach for cutaneous melanoma?Cancer Chemother Pharmacol1993; 32: 392–5.
24.
KusewittDF, ApplegateLA, BucanaCD, LeyRD. Naturally occurring malignant melanoma in the South American opossum (monodelphis domestica).Vet Pathol1990; 27: 66–8.
25.
SetlowRB, WoodheadAD. Temporal changes in the incidence of malignant melanoma: explanation from action spectra.Mutat Res1994; 307: 365–74.
26.
Surveillance, epidemiology, and end results (SEER).Cancer statistics review 1973-1991.National Cancer Institute, 1995: 66–9.
MillerDL, WeinstockMA. Nonmelanoma skin cancer in the United States: incidence.J Am Acad Dermatol1994; 30: 774–8.
29.
WeinstockMA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988.Arch Dermatol1993; 129: 1286–90.
30.
KopfAW, KripkeML, SternRS. Sun and malignant melanoma.J Am Acad Dermatol1984; 11(4 pt 1): 674–84.
31.
SwerdlowAJ. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine.Br Med J1979; 2: 1324–7.
32.
MagnusK. Incidence of malignant melanoma of the skin in Norway 1955-1970. Variations in time and space and solar radiation.Cancer1973; 32: 1275–86.
33.
EklundG, MalecE. Sunlight and incidence of cutaneous malignant melanoma. Effect of latitude and domicile in Sweden.Scand J Plast Reconstr Surg1978; 12: 231–41.
34.
TeppoL, PakkanenM, HakulinsenT. Sunlight as a risk factor of malignant melanoma of the skin.Cancer1978; 41: 2018–27.
35.
ElwoodJM, LeeJA, WalterSD, MoT, GreenAE. Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada.Int J Epidemiol1974; 3: 325–32.
36.
ScottoJ, FearsTR. The association of solar ultraviolet and skin melanoma incidence among Caucasians in the United States.Cancer Invest1987; 5: 275–83.
37.
PitcherHM, LongstrethJD. Melanoma mortality and exposure to ultraviolet radiation: an empirical relationship.Environ Int1991; 17: 7–21.
38.
FearsTR, ScottoJ, SchneidermanMA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States.Am J Epidemiol1977; 105: 420–7.
39.
MuirC, WaterhouseJ, MackT, PowellJ, WhelanS. Cancer incidence in five continents. No 88 ed. Lyon: IARC Scientific Publications,1987: 40–4.
40.
WhelanSL, ParkinDM, MasuyerE. Patterns of cancer in five continents. No 102 ed. Lyon: IARC Scientific Publications,1990: 29–32.
41.
Cannon-AlbrightLA, MeyerLJ, GoldgarDE. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).Cancer Res1994; 54: 6041–4.
42.
RichardMA, GrobJJ, GouvernetJ. Role of sun exposure on nevus. First study in age-sex phenotype-controlled populations.Arch Dermatol1993; 129: 1280–5.
43.
GarbeC, ButtnerP, WeissJ. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Registry of the German Dermatological Society.J Invest Dermatol1994; 102: 700–5.
44.
TierstenAD, GrinCM, KopfAW. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.J Dermatol Surg Oncol1991; 17: 44–8.
45.
MarghoobAA, KopfAW, RigelDS. Risk of malignant melanoma for patients with “classic” atypical-mole syndrome.Melanoma Lett1994; 12: 1–2.
46.
SladeJ, MarghoobAA, SalopekTG. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.J Am Acad Dermatol1995; 32: 479–94.
47.
CrombieIK. Distribution of malignant melanoma on the body surface area.Br J Cancer1981; 43: 842–9.
48.
ElwoodJM, GallagherRP. Site distribution of malignant melanoma.Can Med Assoc J1983; 128: 1400–4.
49.
LarueL, DoughertyN, MintzB. Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes.Proc Natl Acad Set U S A1992; 89: 9534–8.
50.
SetlowRB, WoodheadAD, GristE. Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid.Proc Natl Acad Sci U S A1989; 86: 8922–6.
51.
SetlowRB, GristE, ThompsonK, WoodheadAD. Wavelengths effective in induction of malignant melanoma.Proc Natl Acad Sci U S A1993; 90: 6666–70.
52.
World Health Organization.Evaluation of carcinogenic risks to humans.Intl Agency Res Cancer Monogr1992; 55: 100–12.
53.
SwerdlowAJ, EnglishJS, MacKieRM, O'DohertyCJ, HunterJA, ClarkJ. Fluorescent light, ultraviolet lamps, and the risk of cutaneous melanoma.Br Med J1988; 297: 647–50.
54.
WalterSD, MarrettLD, FromL, HertzmanC, ShannonHS, RoyP. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps.Am J Epidemiol1990; 131: 232–43.
55.
FreemanRG. Data on the action spectrum for ultraviolet carcinogenesis.J Natl Cancer Inst1975; 55: 1119–22.
56.
de GruijlFR, SterenborgHJ, ForbesPD, DaviesRE, ColeC, KelfkensG. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice.Cancer Res1993; 53: 53–60.
57.
MortonDL, DavtyanDG, WanekLA, FoshagLJ, CochranAJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.Cancer1993; 71: 373–743.
58.
NaylorMF, BoydA, SmithDW, CameronGS, HubbardD, NeldnerKH. High sun protection factor sunscreens in the supression of actinic neoplasia.Arch Dermatol1995; 131: 170–5.
59.
ThompsonSC, JolleyD, MarksR. Reduction of solar keratoses by regular sunscreen use.N Engl J Med1993; 329: 1147–51.
StillerMJ, DavisIC, ShupackJL. A concise guide to topical sunscreens: state of the art.Int J Dermatol1992; 31: 540–3.
62.
SterlingGB. Sunscreens: a review.Cutis1992; 50: 221–4.
63.
DeSimoneEM. FDA proposes changes in sunscreen regulations.Am Pharm1994; NS34: 26–31.
64.
Drug facts and comparisons.St Louis, MO: Facts and Comparisons,1995: 562a.
65.
BissettDL, McBrideJF, HannonDP. Time-dependent decrease in sunscreen protection against chronic photodamage in UVB-irradiated hairless mouse skin.J Photochem Photobiol B1991; 9: 323–34.
66.
OdioM, VeresD, GoodmanJ. Comparative efficacy of sunscreen reap-plication regimens in children exposed to ambient sunlight.Photodermatol Photoimmunol Photomed1994; 10: 118–25.
67.
ZaynounS, AndersonRR. Cumulative effects of repeated subthreshold doses of ultraviolet radiation.J Invest Dermatol1981; 76: 356–8.
68.
KaidbeyKH. The photoprotective potential of the new superpotent sunscreens.J Am Acad Dermatol1990; 22: 449–52.
69.
ZieglerA, JonasonAS, LeffellDJ, SimonJA, SharmaHW, KimmelmanJ. Sunburn and p53 in the onset of skin cancer.Nature1994; 372: 773–6.
70.
van WeeldenH, van der PutteSC, ToonstraJ, van der LeunJC. UVA-induced tumours in pigmented hairless mice and the carcinogenic risks of tanning with UVA.Arch Dermatol Res1990; 282: 289–94.
71.
Bech-ThomsenN, PoulsenT, ChristensenFG, LundgrenK, WulfHC. UVA tanning devices interact with solar-simulated UV radiation in skin tumor development in hairless mice.Arch Dermatol Res1992; 284: 353–7.
72.
KelfkensG, de GruijlFR, van der LeunJC. Tumorigenesis by short-wave ultraviolet A: papillomas versus squamous cell carcinomas.Carcinogenesis1991; 12: 1377–82.
73.
TalveL, StenbackF, JansenCT. UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice.Photodermatol Photoimmunol Photomed1990; 7: 109–15.
74.
EllerMS, YaarM, GilchrestBA. DNA damage and melanogenesis.Nature1994; 372: 413–4.
75.
FitzpatrickTB. The validity and practicality of sun-reactive skin types I through VI.Arch Dermatol1995; 124: 869–71.
76.
PotterTS, HashimotoK. Cutaneous photosensitivity to medications.Compr Ther1994; 20: 414–7.
MaillouxAT. Photosensitivity and burns. In: YoungLY, Koda-KimbleMA, eds. Applied therapeutics: the clinical use of drugs.6th ed.Vancouver, WA: Applied Therapeutics, Inc.,1995: 39-1–39-15.
80.
UrbachF. Sunscreen not mutagenic (letter).Med J Aust1980; 2: 284.
81.
BoninAM, ArlauskasAP, AngusDS, BakerRS, GallagherCH, Green-oakG. UV-absorbing and other sun-protecting substances: genotoxicity of 2-ethylhexyl p-methoxycinnamate.Mutat Res1982; 105: 303–8.
82.
HendersonL, FedykJ, BoumerC, WindebankS, FletcherS, LovellW. Photomutagenicity assays in bacteria: factors affecting assay design and assessment of photomutagenic potential of para-aminobenzoic acid.Mutagenesis1991; 9: 459–65.
83.
DeanSW, LaneM, DunmoreRH, RuddockSP, MartinCN, KirklandDJ. Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light-I. Assay development.Mutagenesis1991; 6: 335–41.
84.
GichnerT, BaburekI, VeleminshyJ, KappasA. UV-irradiation potentiates the antimutagenicity of p-aminobenzoic and p-aminosalicylic acids in Salmonella typhimurium.Mutat Res1991; 249: 119–23.
85.
KnowlandJ, McKenzieEA, McHughPJ, CridlandNA. Sunlight-induced mutagenicity of a common sunscreen ingredient.FEBS Lett1993; 324: 309–13.
86.
MondonP, ShahinMM. Protective effect of two sunscreens against lethal and genotoxic effects of UVB in V79 Chinese hamster cells and Saccharomyces cerevisiae strains XV185-14C and D5.Mutat Res1992; 279: 121–8.
87.
GallagherCH, GreenoakGE, ReeveVE, CanfieldPJ, BakerRS, BoninAM. Ultraviolet carcinogenesis in the hairless mouse skin: influence of the sunscreen 2-ethylhexyl-p-methoxycinnamate.Aust J Exp Biol Med Sci1984; 62(pt 5): 577–88.
